CSAM Health Group AS

CSAM Health Group AS

CSAMF
CSAM Health Group ASUS flagOther OTC
4.82
USD
- -
- -
98.80MMarket Cap
CSAM Health Group AS
CSAMF
(Other OTC)

Recent

price

4.82

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
5.25
8
9.82
10.93
15.71
17.49
20.1
20.72
21.69
Revenue per Share
-0.7
-0.55
-1.73
-0.44
-4.13
-6.28
5.11
-3.25
-1.88
Basic EPS, GAAP
0.06
-1.63
-2.41
1.35
1.05
0.55
1.91
6.45
4.1
Free Cash Flow per Basic Share
- -
- -
0.2
3.83
- -
- -
- -
0.47
0.48
Dividend per Share
0.2
0.07
0.08
0.1
0.1
0.1
0.1
0.1
0.1
Book Value per Share
-6
-6.24
-9.57
0.02
-11.47
-16.37
-20.18
-25.21
-26.33
Tangible Book Value per Share
21
21
21
21
21
21
20
21
20
Basic Weighted Avg Shares
110
167
205
229
329
367
410
425
441
Sales/Revenue/Turnover
-9.32
4.02
-9.26
7.55
-12.7
-19.98
-1.97
-0.53
3.78
Operating Margin (%)
29
35
55
41
84
89
-65
51
58
Depreciation Expense
-15
-11
-36
-9
-87
-132
104
-67
-38
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-13.38
-6.86
-17.64
-4.04
-26.29
-35.89
25.42
-15.7
-8.67
Profit Margin (%)
-35
-27
-63
242
237
138
52
-45
-59
Working Capital
118
135
170
284
491
494
477
483
485
LT Debt
46
60
34
248
172
29
95
17
33
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-413.51
-2,338
-496.42
-4,133.86
-6,275.54
4,976.16
-3,182.02
-1,806.95
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'24
Dec'24
Mar'25
ST Debt
- -
- -
- -
LT Borrowings
482
483
485
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
21
21
Market Capitalization
1,037
1,117
1,094

Working Capital

FRC

in mil. unless spec.
Sep'24
Dec'24
Mar'25
Total Current Assets
142
211
161
Cash, Cash Equivalents & STI
52
118
60
Accounts Receivable, Net
28
37
34
Inventories
2
- -
- -
Total Current Liabilities
123
256
220
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
132.21%
-82.1%
Free Cash Flow
- -
49.75%
239.82%
Net Income, GAAP
- -
94.5%
-163.95%
Sales/Revenue/Turnover
- -
16.44%
3.53%
Total Cash Common Dividend
- -
- -
-87.82%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
102
104
97
109
410
2024
105
104
100
115
425
2025
121
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
0.13
-1.24
6.11
0.27
5.11
2024
-0.65
-1.16
0.49
-1.57
-3.25
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
0.48
- -
- -
0.47
2025
- -
- -
- -
- -
- -
Business
Omda AS, known previously as CSAM Health Group AS, delivers a comprehensive portfolio of specialized eHealth solutions across Norway and internationally, facilitating smarter ways to a safe and healthy world. The company offers advanced software supporting clinical workflows and critical decision-making for healthcare professionals and emergency responders. Its offerings include robust tools for connected imaging, such as integrated teleradiology systems like Arcidis, alongside DICOM servers for managing radiology data. This segment also encompasses web-based medical imaging, comprehensive image management, and workflow solutions, exemplified by products like Media, Medimaker, Picsara, TRIS, and Cardio for ECG and diagnostic storage, alongside KIBI's medical imaging solutions. For women and child health, Omda provides dedicated systems for maternity care, including solutions like Partus and Natus, web-based labor information systems such as iPana Labor, and cloud-based platforms like iPana Maternity for electronic medical information sharing between expectant mothers and clinics. Additionally, its portfolio extends to fertility care and practice management with offerings like Fertsoft. The firm’s emergency and public safety domain features crucial solutions like AMIS, an emergency medical information system, IMTS for patient assessment and prioritization, and Paratus, an emergency response system. This area is further strengthened by operational planning tools such as Optima Predict and Optima Live, along with systems like CoordCom and ResQMobile for command and control. Complementary solutions include secure HelseMail for confidential patient data exchange, Infobroker for vendor-neutral telemedicine, S7 for self-care and health counseling, and Web Client for unified access to applications. Its XDS platform provides a central archive for diverse clinical patient data. Furthermore, Omda delivers specialized laboratory and medication management solutions, including Cytodose for oncology management and ProSang, an advanced laboratory information management system widely used for blood management. The company has expanded its health analytics capabilities through strategic acquisitions, offering unified patient data solutions for life sciences, healthcare, and research. Omda AS was established in 1999 and maintains its headquarters in Oslo, Norway.